Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Cuvinte cheie:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideRezumat
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Descărcări
Publicat
Număr
Secțiune
Licență
Copyright (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Această lucrare este licențiată în temeiul Creative Commons Attribution-NonCommercial 4.0 International License.
